|
|
|
|
|
|
by SpeakMouthWords
3451 days ago
|
|
|
From the article: >It was the biggest biotech IPO ever in the U.S., raising $360 million. It has largely held up, too. Axovant’s shares, which opened at $15, currently trade around $13.25. and further down: > When Axovant went public, a columnist at FierceBiotech warned that it should “scare the hell” out of investors |
|
|